阿瑞匹坦作为一种止痒剂？ - Suppr

Suppr

超能文献

Aprepitant as an antipruritic agent?

作者信息

Duval Arnaud, Dubertret Louis

出版信息

N Engl J Med. 2009 Oct 1;361(14):1415-6. doi: 10.1056/NEJMc0906670.

DOI:10.1056/NEJMc0906670

PMID:19797294

Abstract

摘要

相似文献

Aprepitant as an antipruritic agent?阿瑞匹坦作为一种止痒剂？

N Engl J Med. 2009 Oct 1;361(14):1415-6. doi: 10.1056/NEJMc0906670.

Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues.阿瑞匹坦：其对难治性瘙痒患者有效性的证据仍在不断涌现。

J Am Acad Dermatol. 2012 Jan;66(1):e14-5. doi: 10.1016/j.jaad.2011.01.016.

Topical aprepitant in clinical and experimental pruritus.局部应用阿瑞匹坦治疗临床和实验性瘙痒症。

Arch Dermatol. 2012 Aug;148(8):957-9. doi: 10.1001/archdermatol.2012.1018.

Aprepitant for the Treatment of Pruritus in Sézary Syndrome: A Randomized Crossover Clinical Trial.阿瑞匹坦治疗蕈样肉芽肿病瘙痒的随机交叉临床试验。

JAMA Dermatol. 2018 Oct 1;154(10):1221-1222. doi: 10.1001/jamadermatol.2018.2510.

Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.用阿瑞匹坦治疗早期色素减退型蕈样肉芽肿的瘙痒症。

Dermatol Ther. 2014 May-Jun;27(3):178-82. doi: 10.1111/dth.12113. Epub 2013 Dec 2.

Aprepitant against pruritus in patients with solid tumours.阿瑞匹坦用于实体瘤患者的止痒治疗。

Support Care Cancer. 2010 Sep;18(9):1229-30. doi: 10.1007/s00520-010-0895-9. Epub 2010 Jun 11.

Aprepitant for erlotinib-induced pruritus.阿瑞匹坦用于治疗厄洛替尼引起的瘙痒。

N Engl J Med. 2010 Jul 22;363(4):397-8. doi: 10.1056/NEJMc1003937.

[Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist].[恶心和呕吐的预防。阿瑞匹坦，首个作用于NK-1受体的治疗性拮抗剂]

Pharm Unserer Zeit. 2007;36(5):373-80. doi: 10.1002/pauz.200700234.

[Role of aprepitant in the management of pruritus in a patient with cutaneous T-cell lymphoma].[阿瑞匹坦在皮肤T细胞淋巴瘤患者瘙痒管理中的作用]

Farm Hosp. 2014 Apr 1;38(2):145-7.

Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma.口服阿瑞匹坦治疗红皮病型皮肤T细胞淋巴瘤难治性瘙痒

Br J Dermatol. 2011 Mar;164(3):665-7. doi: 10.1111/j.1365-2133.2010.10108.x. Epub 2011 Jan 28.

引用本文的文献

An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.原发性皮肤 T 细胞淋巴瘤瘙痒机制及其潜在治疗方法的最新进展。

Clin Exp Med. 2023 Dec;23(8):4177-4197. doi: 10.1007/s10238-023-01141-x. Epub 2023 Aug 9.

Mechanisms and treatments of neuropathic itch in a mouse model of lymphoma.淋巴瘤小鼠模型中神经性瘙痒的机制和治疗方法。

J Clin Invest. 2023 Feb 15;133(4):e160807. doi: 10.1172/JCI160807.

[Quality of life of patients with mycosis fungoides and Sézary syndrome].[蕈样肉芽肿和塞扎里综合征患者的生活质量]

Dermatologie (Heidelb). 2022 Oct;73(10):759-764. doi: 10.1007/s00105-022-05049-7. Epub 2022 Sep 8.

S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.S2k指南 - 皮肤淋巴瘤（ICD10 C82 - C86）：2021年更新

J Dtsch Dermatol Ges. 2022 Apr;20(4):537-554. doi: 10.1111/ddg.14706.

Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk.瘙痒：一种在皮肤免疫-神经相互作用中产生的感觉症状。

Front Pharmacol. 2022 Mar 7;13:745658. doi: 10.3389/fphar.2022.745658. eCollection 2022.

A case of severe paraneoplastic itch resistant to antihistamines and responding to serotonin reuptake inhibitors.一例对抗组胺药耐药且对5-羟色胺再摄取抑制剂有效的严重副肿瘤性瘙痒病例。

Clin Case Rep. 2021 Jul 6;9(7):e04279. doi: 10.1002/ccr3.4279. eCollection 2021 Jul.

Neurokinin 1 Receptor Antagonists for Pruritus.神经激肽 1 受体拮抗剂治疗瘙痒。

Drugs. 2021 Apr;81(6):621-634. doi: 10.1007/s40265-021-01478-1. Epub 2021 Mar 6.

Emerging Therapeutic Options for Chronic Pruritus.慢性瘙痒的新兴治疗选择

Am J Clin Dermatol. 2020 Oct;21(5):601-618. doi: 10.1007/s40257-020-00534-y.

Emerging Research in Chronic Pruritus: From Bedside to Bench and Back Again.慢性瘙痒的新兴研究：从床边到实验台，再回归床边

Medicines (Basel). 2020 Apr 29;7(5):24. doi: 10.3390/medicines7050024.

Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial.神经激肽-1 拮抗剂奥那司坦治疗癌症患者表皮生长因子受体抑制剂相关瘙痒：一项随机、安慰剂对照的 II 期试验。

BMJ Open. 2020 Feb 6;10(2):e030114. doi: 10.1136/bmjopen-2019-030114.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验